142 related articles for article (PubMed ID: 21436763)
1. Crossreactivity of bupropion metabolite with enzyme-linked immunosorbent assays designed to detect amphetamine in urine.
Reidy L; Walls HC; Steele BW
Ther Drug Monit; 2011 Jun; 33(3):366-8. PubMed ID: 21436763
[TBL] [Abstract][Full Text] [Related]
2. Bupropion interference with immunoassays for amphetamines and LSD.
Vidal C; Skripuletz T
Ther Drug Monit; 2007 Jun; 29(3):373-5. PubMed ID: 17529897
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Cozart Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid.
Cooper G; Wilson L; Reid C; Hand C; Spiehler V
Forensic Sci Int; 2006 Jun; 159(2-3):104-12. PubMed ID: 16115742
[TBL] [Abstract][Full Text] [Related]
4. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
Eichhorst J; Etter M; Lepage J; Lehotay DC
Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
Stout PR; Klette KL; Horn CK
J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
[TBL] [Abstract][Full Text] [Related]
6. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH].
Lin WL; Deng JF; Chou LJ; Hung DZ; Tsai WJ
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):305-9. PubMed ID: 1659927
[TBL] [Abstract][Full Text] [Related]
7. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay.
Casey ER; Scott MG; Tang S; Mullins ME
J Med Toxicol; 2011 Jun; 7(2):105-8. PubMed ID: 21191682
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
Moriya F; Hashimoto Y
Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
[TBL] [Abstract][Full Text] [Related]
9. Validation of LUCIO-Direct-ELISA kits for the detection of drugs of abuse in urine: application to the new German driving licence re-granting guidelines.
Agius R; Nadulski T; Moore C
Forensic Sci Int; 2012 Feb; 215(1-3):38-45. PubMed ID: 22075096
[TBL] [Abstract][Full Text] [Related]
10. Clinical issues associated with urine testing of substances of abuse.
Eskridge KD; Guthrie SK
Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
[TBL] [Abstract][Full Text] [Related]
11. Varying results for immunoassay screening kits for cotinine level.
Alterman AI; Gariti P; Niedbala RS
Psychol Addict Behav; 2002 Sep; 16(3):256-9. PubMed ID: 12236461
[TBL] [Abstract][Full Text] [Related]
12. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
[TBL] [Abstract][Full Text] [Related]
14. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
15. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
16. [False positive screening for drugs of abuse].
Watine J
Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
[No Abstract] [Full Text] [Related]
17. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
Lachenmeier K; Musshoff F; Madea B
Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
[TBL] [Abstract][Full Text] [Related]
18. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
George S; Braithwaite RA
Addiction; 1995 Feb; 90(2):227-32. PubMed ID: 7703816
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
Maresová V; Chadt J; Prikryl L
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
[TBL] [Abstract][Full Text] [Related]
20. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples.
Kankaanpää A; Gunnar T; Ariniemi K; Lillsunde P; Mykkänen S; Seppälä T
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):57-68. PubMed ID: 15358308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
